Skip to content
Results research

Concall Intelligence

Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search official call evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.

Open reported results
Matching calls
85
After selected filters
Transcript verified
33
Official transcript summaries on this page
Preliminary briefs
17
Presentation evidence, clearly labelled
Processing
0
Transcript filed or call source found
Tracked companies
0
Watchlist or portfolio matches

Management evidence

Generated 23 Oct, 12:32 am IST · click a summary to inspect source-linked evidence for this results quarter.

Clear filters
CompanyCall and sourcesReported resultManagement outlookEvidence-led conclusionReview
CREDITACC
CREDITACCESS GRAMEEN LIMITED
Financial Services · Small
Sept 2026
22 Oct 2026
Preliminary brief
Excellent
85/100
Optimistic outlook
No comparable prior call
Guidance raised

CreditAccess Grameen Limited reported strong financial and operating performance for Q2 FY27, driven by robust AUM growth, improving asset quality back to pre-crisis levels, and higher profitability resulting in the highest-ever quarterly PAT crossing INR 500 Cr. Management revised FY27 performance guidance upwards across key return and margin metrics, supported by disciplined operating costs and strong capital positions.

Evidence summary ready
HSCL
Himadri Speciality Chemical Limited
Chemicals · Small
Sep 2026
22 Oct 2026
Preliminary brief
Good
62/100
Optimistic outlook
No comparable prior call
No measurable guidance

Himadri Speciality Chemical Limited delivered robust consolidated revenue growth of 57.93% YoY to Rs. 1691.43 Cr and PAT growth of 31.33% YoY to Rs. 231.32 Cr for Q2 FY27, driven by scaling operations and value-added product expansion. However, significant working capital pressures resulted in negative net operating cash flows for H1 FY27.

Evidence summary ready
HAVELLS
Havells India Limited
Consumer · Mid
Sept 2026
22 Oct 2026
Preliminary brief
Average
32/100
Optimistic outlook
No comparable prior call
No measurable guidance

Havells India Limited reported strong revenue growth of 34.6% YoY to Rs 6,417 crores for Q2 FY27, driven by robust performance across segments including a 47.9% jump in Cables and a 147.8% surge in Renewables. However, profitability was tempered by commodity volatility in aluminium impacting cable contribution margins and continued losses in the Lloyd Consumer segment.

Evidence summary ready
AURUM
Aurum PropTech Limited
IT · Small
Sep 2026
22 Oct 2026
Transcript verified
Average
32/100
Optimistic outlook
No comparable prior call
No measurable guidance

Aurum PropTech reported Q2 FY27 revenue of 130.2Cr (up 64% YoY) and PAT of 4.3Cr, marking its fourth consecutive profitable quarter. The acquisition of Housing.com on September 29, 2026, roughly doubled its balance sheet and added 1,020Cr in carryforward losses. Management emphasized unit economic discipline, deep cost cuts at Housing, and a clear integration roadmap targeting profitability for Housing within 12 to 18 months.

Evidence summary ready
ORIENTELEC
Orient Electric Limited
Power · Small
Sep 2026
22 Oct 2026
Transcript verified
Excellent
90/100
Optimistic outlook
No comparable prior call
No measurable guidance

Orient Electric delivered strong top-line and operating profit growth in Q2 FY27, driven by robust performance across fans, lighting, and emerging categories like wires and switchgear, though gross margins remained pressured due to persistent commodity inflation.

Evidence summary ready
SOUTHBANK
The South Indian Bank Limited
Financial Services · Micro
Sept 2026
22 Oct 2026
Transcript verified
Good
70/100
Optimistic outlook
No comparable prior call
Guidance maintained

The South Indian Bank reported its highest-ever quarterly net profit of INR426.3 crores for Q2 FY27, driven by strong advances and deposit growth, along with significant asset quality improvements and a lower credit cost.

Evidence summary ready
ROSSARI
Rossari Biotech Limited
Pharma · Small
Sep 2026
22 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Cautious outlook
No comparable prior call
No measurable guidance

Rossari Biotech delivered its highest-ever quarterly revenue and EBITDA in Q2 FY27, supported by broad-based divisional growth and an improving export share. However, management remains cautious due to raw material volatility, Middle East geopolitical tensions impacting freight and logistics, and constrained ethylene oxide availability.

Evidence summary ready
FEDFINA
Fedbank Financial Services Limited
Financial Services · Micro
Sept 2026
22 Oct 2026
Transcript verified
Excellent
85/100
Optimistic outlook
No comparable prior call
Guidance maintained

Fedbank Financial Services Limited delivered a strong Q2 FY27 with total disbursements up 28% YoY to INR6,676 crores and AUM up 37% YoY to INR22,035 crores. PAT reached INR130.8 crores (up 63% YoY), driven by an expanded ROA of 2.8% and ROE of 17%. Management highlighted that heightened competitive intensity in the gold loan market was managed effectively without compromising yields significantly, while mortgage collections and credit costs improved.

Evidence summary ready
MAHLIFE
Mahindra Lifespace Developers Limited
Real Estate · Small
Sept 2026
22 Oct 2026
Preliminary brief
Bad
15/100
Optimistic outlook
No comparable prior call
No measurable guidance

Mahindra Lifespace Developers Limited reported mixed financial performance for Q2 FY27 with consolidated revenue of Rs 32.4 Cr and PAT of Rs 16.3 Cr, alongside strong operational pre-sales of Rs 1,063 Cr and healthy business development momentum with Rs 7,100 Cr in H1 GDV additions.

Evidence summary ready
IIFL
IIFL Finance Limited
Financial Services · Small
Sep 2026
22 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
Guidance maintained

IIFL Finance reported robust performance for Q2 FY27, with consolidated AUM reaching INR1,24,268 crores (up 38% YoY and 8% QoQ) and consolidated PAT crossing INR805 crores, up 13% QoQ and 93% YoY. The return on equity surpassed the 20% target at 20.1%, supported by steady asset quality (consolidated gross NPA improved by 7 bps QoQ to 1.48%), increased liquidity of INR13,805 crores, and stable capital adequacy of 23.5%. However, management faces challenges including capital-ra

Evidence summary ready
THELEELA
Leela Palaces Hotels & Resorts Limited
Consumer · Large
Sep 2026
22 Oct 2026
Transcript verified
Excellent
85/100
Optimistic outlook
No comparable prior call
Guidance maintained

Leela Palaces Hotels & Resorts delivered exceptional performance in Q2 FY27 with 33% operating revenue growth and 36% EBITDA growth, supported by robust luxury demand, pricing power, and strong performance during marquee events like the BRICS summit in New Delhi.

Evidence summary ready
JINDALSAW
Jindal Saw Limited
Industrials · Large
Sept 2026
22 Oct 2026
Transcript verified
Bad
0/100
Optimistic outlook
No comparable prior call
Guidance maintained

Jindal Saw delivered higher year-on-year revenues for Q2 FY27 but faced severe operational margin compression due to geopolitical tensions in West Asia delaying shipments, higher international/domestic logistics costs, soaring coking coal prices, and softness in the domestic water infrastructure segment.

Evidence summary ready
TATACOMM
Tata Communications Limited
Telecom · Mid
Sept 2026
22 Oct 2026
Preliminary brief
Excellent
80/100
Optimistic outlook
No comparable prior call
No measurable guidance

Tata Communications Limited delivered a strong financial performance in Q2FY27 with robust YoY growth in revenue and PAT, supported by improving digital margins, though digital portfolio remains on the path to breakeven.

Evidence summary ready
IRFC
Indian Railway Finance Corporation Limited
Financial Services · Large
Sep 2026
22 Oct 2026
Transcript verified
Average
50/100
Optimistic outlook
No comparable prior call
Guidance maintained

IRFC reported a robust performance for Q2 FY26-27, driven by successful business diversification and double-digit PAT growth across five of the last six quarters. Management remains confident in achieving its near-term and long-term AUM and profitability milestones while maintaining a low weighted average cost of capital.

Evidence summary ready
AYE
Aye Finance Limited
Financial Services · Small
Sept 2026
22 Oct 2026
Preliminary brief
Excellent
85/100
Optimistic outlook
No comparable prior call
Guidance maintained

Aye Finance Limited delivered a strong operational and financial performance in Q2 FY27, driven by robust AUM growth, improving asset quality, and record quarterly profitability supported by enhanced operational efficiency and lower credit costs.

Evidence summary ready
ELECON
Elecon Engineering Company Limited
Industrials · Large
Sept 2026
22 Oct 2026
Transcript verified
Good
55/100
Optimistic outlook
No comparable prior call
Guidance maintained

Elecon delivered resilient H1 FY27 performance with 11% consolidated revenue growth and a stable EBITDA margin of 22.2%, supported by robust international momentum in gears and recovering project clearances in the MHE division despite near-term domestic softness and raw material volatility.

Evidence summary ready
SRF
SRF Limited
Chemicals · Mid
Sept 2026
22 Oct 2026
Preliminary brief
Average
52/100
Optimistic outlook
No comparable prior call
No measurable guidance

SRF Limited reported a consolidated revenue of 4,904.2 Cr and a PAT of 509.1 Cr for Q2 FY27, backed by robust growth in the Chemicals and Performance Films businesses, while navigating elevated input, freight, and fuel costs.

Evidence summary ready
LTM
LTM Limited
IT · Large
Sept 2026
22 Oct 2026
Transcript verified
Bad
0/100
Optimistic outlook
No comparable prior call
Guidance maintained

LTM Limited reported steady Q2 FY2027 performance with 1.1% QoQ constant currency revenue growth and stable EBIT margins of 15.6%, while pivoting strongly toward AI-centric offerings and advancing strategic M&A execution.

Evidence summary ready
KROSS
Kross Limited
Auto · Small
Sep 2026
22 Oct 2026
Transcript verified
Excellent
100/100
Optimistic outlook
No comparable prior call
No measurable guidance

Kross Limited delivered strong Q2 FY '27 financial results driven by robust M&HCV and trailer segment demand, capacity expansion, and improving wallet share, though margins faced pressure from rising commodity and consumable costs.

Evidence summary ready
TECHM
Tech Mahindra Limited
IT · Large
Sep 2026
21 Oct 2026
Transcript verified
Excellent
80/100
Optimistic outlook
No comparable prior call
No measurable guidance

Tech Mahindra delivered strong revenue and profit growth, highlighted AI and vertical wins, and expressed confidence in sustaining momentum into the December quarter.

Evidence summary ready
INDHOTEL
The Indian Hotels Company Limited
Consumer · Large
Sept 2026
21 Oct 2026
Preliminary brief
Average
52/100
Optimistic outlook
No comparable prior call
Guidance raised

The Indian Hotels Company Limited reported strong financial results for Q2 FY27 with 21.7% YoY revenue growth and 19.4% YoY PAT growth, driven by robust domestic hospitality demand, scaling selective service brands, and asset management initiatives.

Evidence summary ready
INDIANB
Indian Bank
Financial Services · Mid
Sept 2026
21 Oct 2026
Transcript verified
Good
60/100
Optimistic outlook
No comparable prior call
Guidance raised

Indian Bank reported a strong set of results for Q2 FY27 with net profit growing 14.71% YoY to Rs.3,462 crore (aided by NSE listing gains), healthy advances growth of 16.39%, and improving asset quality metrics with GNPA at 1.61%. Management has revised its deposit and advances growth guidance upwards for the full year while acknowledging potential headwinds from regulatory changes, potential HTM valuation shocks, and credit cost normalisation under ECL models.

Evidence summary ready
360ONE
360 ONE WAM LIMITED
Financial Services · Mid
Sept 2026
21 Oct 2026
Transcript verified
Bad
0/100
Cautious outlook
No comparable prior call
No measurable guidance

Quarterly results showed modest revenue growth and a decline in profit, while management highlighted strong AUM growth, improved ARR retention, and long‑term profitability targets, but flagged margin pressure from higher costs and reliance on UBS flow execution.

Evidence summary ready
ABSLAMC
Aditya Birla Sun Life AMC Limited
Financial Services · Large
Sept 2026
21 Oct 2026
Preliminary brief
Bad
0/100
Neutral outlook
No comparable prior call
No measurable guidance

The core mutual fund QAAUM grew 4% YoY and equity QAAUM expanded 9% YoY, supported by steady SIP additions. However, PAT declined YoY due to lower other income and higher employee expenses, while alternate assets scaled via mandates.

Evidence summary ready
WAAREERTL
Waaree Renewable Technologies Limited
Industrials · Micro
Sept 2026
21 Oct 2026
Preliminary brief
Bad
2/100
Optimistic outlook
No comparable prior call
No measurable guidance

Waaree Renewable Technologies Limited reported strong top-line growth with Q2 FY27 revenue up 36.5% YoY to Rs 1,057.84 Cr, alongside a healthy unexecuted order book exceeding Rs 5,500 Cr. However, PAT contracted by 29.98% YoY to Rs 81.48 Cr due to higher input costs, employee expenses, and financing costs, leading to margin compression.

Evidence summary ready
CCL
CCL Products (India) Limited
FMCG · Large
Sept 2026
21 Oct 2026
Transcript verified
Average
47/100
Optimistic outlook
No comparable prior call
Guidance maintained

CCL delivered strong Q2 results with double‑digit volume growth and profit expansion, and management reaffirmed its FY27 guidance of ~15% volume and EBITDA growth, while noting coffee price volatility and capacity considerations.

Evidence summary ready
DBCORP
D.B.Corp Limited
Media · Small
Sept 2026
21 Oct 2026
Transcript verified
Bad
0/100
Optimistic outlook
No comparable prior call
Guidance maintained

D.B. Corp reported a decline in Q2 FY27 revenue and PAT due to the festive season (Navaratra) shifting into Q3 and temporary headwinds such as panchayat election codes of conduct, though underlying advertising and EBITDA registered positive single-digit growth on a like-to-like basis.

Evidence summary ready
E2E
E2E Networks Limited
IT · Small
Sept 2026
21 Oct 2026
Transcript verified
Good
55/100
Optimistic outlook
No comparable prior call
No measurable guidance

E2E Networks delivered robust financial performance in Q2 FY27 with triple-digit YoY revenue growth and margin expansion, supported by Blackwell GPU deployment and improved utilization. Management maintains a disciplined approach to capex and avoids speculative guidance.

Evidence summary ready
ICICIPRULI
ICICI Prudential Life Insurance Company Limited
Financial Services · Large
Sep 2026
21 Oct 2026
Transcript verified
Good
65/100
Optimistic outlook
No comparable prior call
No measurable guidance

ICICI Life delivered solid revenue and profit growth despite macro volatility, with strong VNB expansion and margin stability, while emphasizing continued investment in agency distribution and upcoming regulatory reforms.

Evidence summary ready
ANGELONE
Angel One Limited
Financial Services · Small
Sept 2026
21 Oct 2026
Transcript verified
Excellent
90/100
Optimistic outlook
No comparable prior call
Guidance maintained

Angel One delivered resilient Q2 FY27 results with consolidated revenue of 14.3 billion rupees and PAT of 3.35 billion rupees despite subdued capital market volumes. Operating margins expanded significantly year-over-year, supported by operating leverage and a diversified revenue mix.

Evidence summary ready
HDFCAMC
HDFC Asset Management Company Limited
Financial Services · Large
Sept 2026
21 Oct 2026
Transcript verified
Good
55/100
Optimistic outlook
No comparable prior call
No measurable guidance

HDFC Asset Management delivered solid revenue growth and maintained high profitability, while highlighting continued expansion of SIP inflows, alternative platform launches, and disciplined cost management; however, guidance on future revenue mix and margins remains limited.

Evidence summary ready
TIPSMUSIC
Tips Music Limited
Media · Micro
Sept 2026
21 Oct 2026
Transcript verified
Good
62/100
Optimistic outlook
No comparable prior call
Guidance raised

Tips Music delivered strong top‑line and profit growth in Q2 FY27, driven by new releases and catalog performance across digital and non‑digital platforms. Management upgraded FY27 growth guidance but highlighted a front‑loaded content spend, ongoing YouTube Shorts negotiations and a smaller‑film focus for H2.

Evidence summary ready
PIRAMALFIN
Piramal Finance Limited
Financial Services · Small
Sep 2026
19 Oct 2026
Preliminary brief
Excellent
77/100
Optimistic outlook
No comparable prior call
Guidance maintained

Piramal Finance Limited reported strong financial results for Q1 FY27, driven by robust growth in retail lending and a granular Wholesale 2.0 portfolio, while successfully continuing the rundown of legacy wholesale assets. The company maintains solid capitalization, high liquidity coverage, and a steadily improving operating leverage.

Evidence summary ready
IXIGO
Le Travenues Technology Limited
Consumer · Micro
Sep 2026
19 Oct 2026
Preliminary brief
Average
35/100
Optimistic outlook
No comparable prior call
No measurable guidance

Le Travenues Technology Limited (IXIGO) reported resilient Q2 FY27 performance with GTV up 22% YoY and revenue from operations up 13% YoY to Rs 321 Crores, supported by strong growth in Flight and Bus segments and the new Hotel line. PAT reached an all-time high aided by a partial stake sale in Freshbus, while management continues to invest in hotels and AI capabilities.

Evidence summary ready
LTTS
L&T Technology Services Limited
IT · Large
Sept 2026
19 Oct 2026
Preliminary brief
Good
70/100
Optimistic outlook
No comparable prior call
No measurable guidance

The operating thesis remains intact driven by solid sequential constant currency growth, large deal TCV wins exceeding USD 200 million (with AI-led deals over 50%), and expansion in EBIT margins to 16.3%, achieving mid-16% aspirations ahead of schedule.

Evidence summary ready
ULTRACEMCO
UltraTech Cement Limited
Materials · Large
Sept 2026
19 Oct 2026
Preliminary brief
Average
52/100
Optimistic outlook
No comparable prior call
No measurable guidance

UltraTech Cement reported solid year-on-year volume and earnings growth for Q2 FY27 driven by strong structural macro demand, although fuel and raw material cost inflation impacted sequential margins.

Evidence summary ready
SEJALLTD
Sejal Glass Limited
Industrials · Small
Sep 2026
19 Oct 2026
Preliminary brief
Excellent
100/100
Optimistic outlook
No comparable prior call
Guidance maintained

Sejal Glass reported strong year-on-year revenue and profit growth for Q2 FY27, driven by higher capacity utilisation, integration of acquired Glasstech plants, and robust performance from its UAE subsidiary. Management remains optimistic about achieving 25% to 40% revenue growth in FY27, supported by scaling operations and new specialty product launches.

Evidence summary ready
HERITGFOOD
Heritage Foods Limited
FMCG · Micro
Sept 2026
19 Oct 2026
Transcript verified
Bad
0/100
Cautious outlook
No comparable prior call
No measurable guidance

Heritage Foods posted solid top-line growth but margin pressure from higher milk procurement costs led to a 39.5% YoY decline in PAT, while EBITDA margin improved sequentially.

Evidence summary ready
GTPL
GTPL Hathway Limited
Media · Small
Sept 2026
19 Oct 2026
Transcript verified
Bad
2/100
Cautious outlook
No comparable prior call
New guidance

GTPL delivered strong top‑line growth driven by subscriber additions and the ACT acquisition, but profitability remained weak with a negative PAT and a decline in operating EBITDA margin, highlighting the need for integration synergies and margin recovery.

Evidence summary ready
PSB
Punjab & Sind Bank
Financial Services · Small
Sept 2026
19 Oct 2026
Preliminary brief
Excellent
75/100
Optimistic outlook
No comparable prior call
No measurable guidance

Punjab & Sind Bank reported steady financial growth for the quarter ended June 30, 2026, supported by an expanding RAM portfolio, improved asset quality metrics, and higher profitability ratios, although the source document is an investor presentation with earnings transcripts pending.

Evidence summary ready
YESBANK
Yes Bank Limited
Financial Services · Mid
Sep 2026
19 Oct 2026
Preliminary brief
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

Yes Bank reported a Q2FY27 net profit of INR 1,080 crores, up 65% year-on-year, driven by healthy core operating income and steady asset quality, though the Supreme Court judgment on AT-1 bonds remains unrecognised pending assessment.

Evidence summary ready
TATAELXSI
Tata Elxsi Limited
IT · Mid
Sept 2026
19 Oct 2026
Transcript verified
Average
45/100
Optimistic outlook
No comparable prior call
No measurable guidance

Tata Elxsi reported Q2 FY27 operating revenue of INR 1055.7 crores (up 2.3% QoQ in constant currency) and an EBITDA margin of 21.9%, absorbing annual wage hikes through operational leverage and realization of one-offs. While US and India markets performed well, Europe remains soft and sluggish, particularly in automotive. Management expects an upward margin trajectory and better second-half performance compared to the first half.

Evidence summary ready
TATATECH
Tata Technologies Limited
IT · Small
Sep 2026
19 Oct 2026
Transcript verified
Average
32/100
Optimistic outlook
No comparable prior call
No measurable guidance

Tata Technologies delivered solid revenue growth and maintained operating margin despite salary headwinds, but sequential PAT declined and technology solutions revenue fell due to accounting changes.

Evidence summary ready
METROPOLIS
Metropolis Healthcare Limited
Pharma · Micro
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
Guidance maintained

Metropolis Healthcare reported robust strategic positioning during its Investor and Analyst Meet, highlighting strong volume-led growth across B2C and B2B channels, expansion in tier-2/tier-3 towns, and margin expansion levers driven by specialty testing, genomics, and network productivity.

Evidence summary ready
NOVARTIND
Novartis India Limited
Pharma · Small
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

Novartis India Limited is undergoing a complete commercial reset following its acquisition by ChrysCapital. The management aims to transition the company from a flattish revenue trajectory to a high-growth platform by building an internal field force of ~900 representatives, expanding distribution to 25 C&Fs and 4,000-5,000 distributors, executing strategic M&As (such as Minipress XL and ophthalmology in-licensing), and focusing on six core therapy areas.

Evidence summary ready
INDIGOPNTS
Indigo Paints Limited
Consumer · Micro
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

Indigo Paints delivered a strong Q1 FY27 with 18.7% standalone revenue growth and a 42% jump in EBITDA, outperforming the broader paint sector despite initial raw material supply disruptions triggered by the Iran conflict.

Evidence summary ready
SHANKESH
Shankesh Jewellers Limited
Consumer · Micro
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

Shankesh Jewellers Limited reported its maiden Q1 FY27 earnings post listing, highlighting strong top-line and margin expansion driven by product mix and festive demand, though the steep margin trajectory and heavy reliance on short-term working capital require close monitoring.

Evidence summary ready
XTGLOBAL
Xtglobal Infotech Limited
IT · Small
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

Xtglobal Infotech reported steady operating performance for Q1 FY27 with modest revenue growth offset by a shift from onsite to offshore delivery, leading to margin expansion.

Evidence summary ready
FORTIS
Fortis Healthcare Limited
Pharma · Mid
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

Management addressed investor queries following the Delhi High Court order directing a forensic audit related to historical promoter share dissipation and IHH's acquisition, maintaining that operations remain insulated and strategic growth plans are unaffected.

Evidence summary ready
GAJA
Gaja Alternative Asset Management Limited
Financial Services · Micro
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

Gaja Alternative Asset Management Limited reported a steady performance for Q1 FY27 with total income growing 26% YoY to INR51.8 crores and PAT growing 35% YoY to INR27.2 crores, supported by strong institutional interest following its successful IPO.

Evidence summary ready
Method: Deterministic quarterly-result score from reported growth, margin direction and operating leverage. Derived only from extracted, source-linked management evidence. Pending is shown when evidence is insufficient. Measurable claims are separated from general commentary and retain outcome status when later evidence exists. Transcript-verified summaries rank above preliminary presentation briefs and source-only call evidence. Preliminary briefs are replaced automatically when an official transcript is processed. Management outlook and colours describe extracted commentary evidence; they are not buy or sell labels.